Method for synthesizing forxiga intermediate

A synthesis method and intermediate technology, which are applied in the field of dapagliflozin synthesis, can solve the problems of high impurity content, low total yield and low product purity, and achieve the effects of reducing impurity content and improving purity and yield.

Active Publication Date: 2014-10-08
安徽联创生物医药股份有限公司
View PDF2 Cites 19 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] In order to overcome the technical problems of low product purity, high impurity content, and low total yield in

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for synthesizing forxiga intermediate
  • Method for synthesizing forxiga intermediate
  • Method for synthesizing forxiga intermediate

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0029] Example 1

[0030] This example relates to compound (5), 5-bromo-2-chloro-4 ′ -A synthetic method of ethoxydiphenylmethane, including the following steps:

[0031] Step 1: Add 5-bromo-2-chlorobenzoic acid (23.5 g, 0.1 mol) and 120 mL of dry dichloromethane to the flask, stir at room temperature, and add 12.8 mL of oxalyl chloride (0.15 mol) in 3 times within 8 hours. ), after the addition, continue to stir at room temperature for 2 hours until the reaction solution is clear and no more gas is released, then the solvent and excess oxalyl chloride are evaporated under reduced pressure to obtain a concentrated solution of 5-bromo-2-chlorobenzoyl chloride, which is compound ( 2),MS-EI(m / z):253(M + ];

[0032] Step 2: Dissolve 26 g of the above red transparent liquid (containing about 0.1 mol of 5-bromo-2-chlorobenzoyl chloride) in 40 mL of dry dichloromethane, cool to -7 ℃, and add phenylethyl ether (15.8 mL, 0.125 mol), and then add anhydrous aluminum trichloride (14.7 g, 0.11...

Example Embodiment

[0034] Example 2

[0035] This embodiment relates to a compound (5), 5-bromo-2-chloro-4 ′ -A synthetic method of ethoxydiphenylmethane, including the following steps:

[0036] Step 1: Add 5-bromo-2-chlorobenzoic acid (23.5 g, 0.1 mol), 120 mL of dry dichloromethane, and stir at room temperature in the flask. Add 8.5 mL of oxalyl chloride (0. 1 mol), after the addition, continue to stir at room temperature for 2 hours until the reaction solution is clear and no more gas is released, then the solvent and excess oxalyl chloride are evaporated under reduced pressure to obtain a concentrated solution of 5-bromo-2-chlorobenzoyl chloride. Namely compound (2), MS-EI(m / z): 253(M + ];

[0037] Step two, dissolve 26 g of the above red transparent liquid (about 0.1 mol of 5-bromo-2-chlorobenzoyl chloride) in 40 mL of dry dichloromethane, cool to -7 ℃, and add phenylethyl ether (18.9 mL, 0.15 mol), and then add anhydrous aluminum trichloride (14.7 g, 0.11 mol) in three batches, during which th...

Example Embodiment

[0039] Example 3

[0040] This embodiment relates to a compound (5), 5-bromo-2-chloro-4 ′ -A synthetic method of ethoxydiphenylmethane, including the following steps:

[0041] Step 1: Add 5-bromo-2-chlorobenzoic acid (23.5 g, 0.1 mol), 120 mL of dry dichloromethane, and stir at room temperature. Add 17 mL of oxalyl chloride (0. 2 mol), after the addition, continue to stir at room temperature for 2 hours until the reaction solution is clear and no gas is released, and then distill off the solvent and excess oxalyl chloride under reduced pressure to obtain a concentrated solution of 5-bromo-2-chlorobenzoyl chloride , Namely compound (2), MS-EI(m / z):253[M + ];

[0042] Step 2: Dissolve 26 g of the above red transparent liquid (about 0.1 mol of 5-bromo-2-chlorobenzoyl chloride) in 40 mL of dry dichloromethane, cool to -7 ℃, and add phenylethyl ether (12.6 mL, 0.1 mol), and then add anhydrous aluminum trichloride (14.7 g, 0.11 mol) in three batches, during which the temperature is cont...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a method for synthesizing a forxiga intermediate. The method comprises the following steps: step 1, by taking dichloromethane as a solvent, reacting a compound (1) and oxalyl chloride under stirring conditions, performing reduced pressure distillation to remove the dichloromethane, and obtaining a concentrated solution of a compound (2); step 2, by taking the dichloromethane as a solvent, reacting the compound (2) and a compound (3) under the condition that aluminum trichloride serves as a catalyst, wherein the reaction temperature is 20 DEG C below zero to 10 DEG C below zero, the reaction time is 2-4 hours, and obtaining a compound (4); and step (3) by taking THF as a solvent, carrying out a reduction reaction on the compound (4), sodium borohydride and aluminum chloride anhydrous, thereof obtaining a compound (5), namely 5-bromine-2-chloro-4'-ethyoxydiphenylmethane. According to the method, the content of impurities can be reduced, the purity is improved, the yield is improved, and the method is suitable for synthesizing the forxiga intermediate in a large scale.

Description

technical field [0001] The invention relates to the technical field of dapagliflozin synthesis, in particular to a dapagliflozin intermediate 5-bromo-2-chloro-4 ′ - Synthetic method of ethoxydiphenylmethane. . Background technique [0002] Dapagliflozin (dapagliflozin) is a sodium-glucose cotransporter 2 (SGLT2) inhibitor used to treat type 2 diabetes, and can be used as an important choice in diabetes drug treatment. The structural formula of dapagliflozin is shown below. [0003] [0004] Currently, Dapagliflozin can be used as compound (5), namely 5-bromo-2-chloro-4 ′ -Ethoxydiphenylmethane is a starting material, which is synthesized by the following steps: [0005] [0006] Therefore, 5-bromo-2-chloro-4 ′ -Ethoxydiphenylmethane as an important intermediate in the synthesis of dapagliflozin, research on 5-bromo-2-chloro-4 ′ -The synthetic method of ethoxydiphenylmethane is of great significance. [0007] Yu Yankun et al. ("Synthesis of Dapagliflozin", "China ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07C41/18C07C43/225
CPCC07C41/18C07C45/46C07C51/60C07C43/225C07C49/84C07C63/70
Inventor 葛德培吴其华
Owner 安徽联创生物医药股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products